title: Omega-3 triglycerides modify blood clearance and tissue targeting pathways of lipid emulsions.
abstract: Omega-3-rich (n-3) triglycerides (TG) are increasingly recognized as having modulating roles in many physiological and pathological conditions. We questioned whether the catabolism of lipid emulsions would be changed after enrichment with fish oil (n-3) TG as compared to enrichment with omega-6-rich soy oil (n-6) TG. Phospholipid-stabilized emulsions of n-3 TG and n-6 TG were labeled with [(3)H]cholesteryl oleoyl ether and administered by bolus injection to wild-type (WT) mice, mice lacking the low-density lipoprotein receptor (LDL-R) (LDL-R -/-), and apolipoprotein E (apoE) knockout mice (apoE -/-). The effects of exogenous apoE, heparin, Triton WR 1339, and lactoferrin on catabolism of emulsions were also assayed. n-3 TG emulsions were cleared faster from blood and had different extrahepatic tissue targeting compared to n-6 TG emulsions. In apoE -/- and LDL-R -/- mice, blood clearance of n-6 TG emulsions slowed with decreased liver uptake, but no changes were observed in n-3 TG emulsion clearance and tissue uptake compared to WT mice. In WT mice, addition of exogenous apoE to the emulsion increased liver uptake of n-6 TG emulsions but had no impact on n-3 TG emulsions. Pre-injection of heparin increased and Triton WR 1339 and lactoferrin decreased blood clearance of n-6 TG emulsions with little or no effect on n-3 TG emulsions. Liver uptake of n-6 TG emulsions increased after heparin injection and decreased after Triton WR 1339 injection, but uptake of n-3 TG emulsions was not changed. These data show that the catabolism of n-3 TG emulsions and the catabolism of n-6 TG emulsions occur via very different mechanisms. Removal of chylomicron-sized n-6 TG emulsions is modulated by lipoprotein lipase (LPL), apoE, LDL-R, and lactoferrin-sensitive pathways. In contrast, clearance of chylomicron-sized n-3 TG emulsions relies on LPL to a very minor extent and is independent of apoE, LDL-R, and lactoferrin-sensitive pathways.
authors.affiliation: Institute of Human Nutrition and Department of Pediatrics, Columbia University, New York, New York 10032, USA.
authors.forename: Kemin
authors.initials: K
authors.lastname: Qi
authors.forename: Toru
authors.initials: T
authors.lastname: Seo
authors.forename: Maysoon
authors.initials: M
authors.lastname: Al-Haideri
authors.forename: Tilla S
authors.initials: TS
authors.lastname: Worgall
authors.forename: Tikva
authors.initials: T
authors.lastname: Vogel
authors.forename: Yvon A
authors.initials: YA
authors.lastname: Carpentier
authors.forename: Richard J
authors.initials: RJ
authors.lastname: Deckelbaum
mesh_terms: D000818:Animals; D001057:Apolipoproteins E / Q000378:metabolism; D005217:Fat Emulsions, Intravenous / Q000493:pharmacokinetics*; D005260:Female; D005347:Fibroblasts / Q000378:metabolism; D005395:Fish Oils / Q000493:pharmacokinetics*; D007781:Lactoferrin / Q000378:metabolism; D008071:Lipoprotein Lipase / Q000378:metabolism; D008657:Metabolic Clearance Rate; D051379:Mice; D008810:Mice, Inbred C57BL; D023421:Models, Animal; D011973:Receptors, LDL / Q000378:metabolism; D013024:Soybean Oil / Q000493:pharmacokinetics*; D014018:Tissue Distribution; D014280:Triglycerides / Q000737:chemistry / Q000493:pharmacokinetics*
chemical_list: D001057:Apolipoproteins E; D005217:Fat Emulsions, Intravenous; D005395:Fish Oils; D011973:Receptors, LDL; D014280:Triglycerides; D013024:Soybean Oil; D008071:Lipoprotein Lipase; D007781:Lactoferrin